<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04384094</url>
  </required_header>
  <id_info>
    <org_study_id>TE0X_EST_2</org_study_id>
    <nct_id>NCT04384094</nct_id>
  </id_info>
  <brief_title>Defining the Operating Parameters for a Rebound-esthesiometer</brief_title>
  <official_title>Rebound Esthesiometer Phase 2 Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icare Finland Oy</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icare Finland Oy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to define the operating parameters for a new method to measure
      corneal sensitivity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Corneal sensitivity is the most important protective mechanism of the eye. Thus, measuring it
      at any given time gives important indicators of corneal physiology, especially in the
      diagnostics of corneal and systemic diseases (e.g. diabetes, herpes simplex and keratitis)
      and recovery from ocular surgery. Current commercial measurement methods are outdated,
      non-quantitative and uncomfortable to use, hence left unused. This results in suboptimal,
      even poor, diagnosis and treatment for patients.

      In this study the operating parameters for a state-of-the-art esthesiometer are defined. The
      operating principle is based on existing rebound technology which is already approved for IOP
      measurement.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rebound esthesiometer operating threshold</measure>
    <time_frame>2020-2021</time_frame>
    <description>Define the corneal touch sensitivity threshold using the rebound esthesiometer by varying the measurement probe impact at the moment of touch of corneal surface. The impact is varied by changing the speed (m/s) of the measurement probe and the subjective sensation of the test subject is recorded. The mass (mg) of the measurement probe is known and the impact energy is calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rebound esthesiometer operating parameters</measure>
    <time_frame>2020-2021</time_frame>
    <description>Measure the correlation of corneal touch sensitivity between rebound esthesiometer and the reference instrument Cochet-Bonnet monofilament esthesiometer. With the rebound esthesiometer the impact is varied by changing the speed (m/s) of the measurement probe. The probe mass (mg) and speed (m/s) equals to the touch impact impulse which causes the touch sensation. The subjective sensation of the test subject is recorded.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Corneal Sensation Reduced</condition>
  <condition>Corneal Dystrophy</condition>
  <condition>Corneal Degeneration</condition>
  <condition>Corneal Transplant Failure</condition>
  <condition>Herpetic Keratitis</condition>
  <arm_group>
    <arm_group_label>Test subjects</arm_group_label>
    <description>Test subjects according to the inclusion / exclusion criterias.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Esthesiometer measurement</intervention_name>
    <description>Measuring the corneal sensitivity using rebound technology.</description>
    <arm_group_label>Test subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects entering ocular primary care examination site and patients entering eye hospital
        for several medical reasons.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 18

          -  Informed consent signed

        Exclusion Criteria:

          -  Signs of infectious or inflammatory disease of anterior eye at the time of
             presentation.

          -  During last two weeks, any of the following events or conditions occurred or was
             present: inflammatory or infectious ocular condition, surgical or other intervention
             or therapy, other abnormal ocular event.

          -  Unable to give informed consent.

          -  Directly or indirectly indicated vunerability.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matjaz Mihelcic, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Optika Mesec</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mika Salkola, M.Sc.</last_name>
    <phone>+358400874054</phone>
    <email>mika.salkola@icarefinland.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Teemu Herranen, B.Sc.</last_name>
    <phone>+358415033680</phone>
    <email>teemu.herranen@icarefinland.com</email>
  </overall_contact_backup>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>esthesiometry</keyword>
  <keyword>corneal sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratitis, Herpetic</mesh_term>
    <mesh_term>Keratitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

